Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

curium netherlands b.v. - tetrakis (2-methylopropyl-isocyanide) copper (i) tetrafluoroborate - kit for radiopharmaceutical preparation - 1 milligram(s) - technetium (99mtc) sestamibi

Marekani - Kiingereza - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - technetium tc-99m sestamibi (unii: 971z4w1s09) (technetium tc-99m sestamibi - unii:971z4w1s09) - technetium tc-99m sestamibi 1 mg in 10 ml - myocardial imaging: technetium tc 99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc 99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent’s labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc 99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc 99m sestamibi is not indicated for breast cancer scree

Kanada - Kiingereza - Health Canada

lantheus mi canada inc - tetrakis [cu(mibi)4]bf4 - powder for solution - 1mg - tetrakis [cu(mibi)4]bf4 1mg - radioactive agents

Kanada - Kiingereza - Health Canada

curium canada inc - tetrakis [cu(mibi)4]bf4 - kit - 1mg - tetrakis [cu(mibi)4]bf4 1mg - roentgenography

Marekani - Kiingereza - NLM (National Library of Medicine)

b. braun medical inc. - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: - glycerin 3 g in 100 ml - procalamine® is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. renal failure. severe liver disease and hepatic coma. metabolic disorders associated with impaired nitrogen utilization. hypersensitivity to one or more amino acids.